HealthStream Receives a Buy from Barrington

In a report released today, Vincent Colicchio from Barrington maintained a Buy rating on HealthStream (NASDAQ: HSTM), with a price target of $32. The company’s shares closed yesterday at $25.14.

Colicchio observed:

“We expect the company to generate rapid growth over the next few years as it adds new clients, expands penetration of existing clients and finds new ways to train/educate healthcare professionals.”

According to TipRanks.com, Colicchio is a 3-star analyst with an average return of 6.4% and a 54.3% success rate. Colicchio covers the Technology sector, focusing on stocks such as Sykes Enterprises Inc, Exlservice Holdings, and Convergys Corp.

HealthStream has an analyst consensus of Moderate Buy, with a price target consensus of $27.67.

See today’s analyst top recommended stocks >>

HealthStream’s market cap is currently $802.2M and has a P/E ratio of 81.10. The company has a book value ratio of 2.6724.

Based on the recent corporate insider activity of 32 insiders, corporate insider sentiment is negative on the stock. Most recently, in March 2018, Linda Rebrovick, a Director at HSTM sold 21,000 shares for a total of $508,200.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthStream, Inc. engages in the provision of services to healthcare organizations and other members within the healthcare industry. It operates through the following segments: HealthStream Workforce Solutions; HealthStream Patient Experience Solutions; and HealthStream Provider Solutions.